New radioactive drug targets Hard-to-Treat liver cancer
Disease control
Recruiting now
This pilot study tests a radioactive drug called 177Lu-PSMA-617 in 10 patients with PSMA-positive liver cancer that has spread. The goal is to see if the drug is safe and can shrink tumors. Patients must have already tried one prior treatment.
Phase: PHASE2 • Sponsor: Melissa Lumish • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC